Revolution Medicines (RVMD) Treasury Shares (2019)

Revolution Medicines' Treasury Shares history runs 8 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 33.82% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $5.1 million (up 33.82% YoY), while the FY2025 annual figure was $3.9 million, up 36.56% from the prior year.
• Treasury Shares for Q1 2026 stood at $5.1 million, up from $3.9 million in the prior quarter.
• The five-year high for Treasury Shares was $5.1 million in Q1 2026, with the low at $1.1 million in Q1 2022.
• The 5-year median for Treasury Shares is $2.9 million (2024), against an average of $2.7 million.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares surged 223.62% in 2022, then grew 19.76% in 2025.
• Revolution Medicines' Treasury Shares stood at $1.2 million in 2022, then surged by 83.93% to $2.2 million in 2023, then surged by 31.87% to $2.9 million in 2024, then jumped by 36.56% to $3.9 million in 2025, then soared by 32.12% to $5.1 million in 2026.
• Business Quant data shows RVMD's Treasury Shares at $5.1 million in Q1 2026, $3.9 million in Q4 2025, and $3.8 million in Q3 2025.